Artelo Biosciences ARTL
NASDAQ ARTL
$2.55 -0.10 (-3.77%)
At close: Oct 22, 2026 · 4:00 PM EDT

Artelo Biosciences (ARTL) Other financing activities (2019 - 2020)

Updated

Analysis

Artelo Biosciences (ARTL) Other financing activities (2019 - 2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn
10 Artelo Biosciences 51,409.08 -5.08 Mn -
Historic Data

Historic Data

Download Data
DateValue
Nov 30, 2020 -1.01 Mn
May 31, 2020 -98,715.00
Nov 30, 2019 -15,151.00
API Access

Artelo Biosciences Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=ARTL&period=max&api_key=YOUR_API_KEY